当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析

海翔药业

(002099)

  

流通市值:83.69亿  总市值:83.85亿
流通股本:16.16亿   总股本:16.19亿

海翔药业(002099)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.08亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益514014.40万元,未分配利润48443.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产759294.22万元,负债245279.82万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入486,432,558.841,938,465,657.861,444,477,964.621,038,840,461.32
营业总成本466,678,445.961,859,241,448.521,375,713,221.67962,350,478.7
营业利润15,998,250.07-336,143,325.921,715,558.0635,205,565.13
利润总额12,599,014.68-336,881,230.273,086,801.4436,499,771.8
净利润8,313,435.12-333,887,461.9110,234,312.6236,718,718.88
其他综合收益-3,828,942.94--
综合收益总额8,313,435.12-330,058,518.9710,234,312.6236,718,718.88
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,123,540,366.392,890,751,484.572,775,226,104.052,839,434,160.58
非流动资产合计4,469,401,830.024,565,292,621.84,834,704,756.114,792,632,120.08
资产总计7,592,942,196.417,456,044,106.377,609,930,860.167,632,066,280.66
流动负债合计2,362,252,433.482,228,294,388.642,054,055,029.191,996,062,395.46
非流动负债合计90,545,804.4495,919,194.3695,340,411.11148,984,059.08
负债合计2,452,798,237.922,324,213,5832,149,395,440.32,145,046,454.54
归属于母公司股东权益合计5,148,301,694.145,139,071,751.735,466,912,403.085,493,035,141.84
股东权益合计5,140,143,958.495,131,830,523.375,460,535,419.865,487,019,826.12
负债和股东权益合计7,592,942,196.417,456,044,106.377,609,930,860.167,632,066,280.66
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计415,838,037.11,547,184,004.11,218,568,767.71849,581,261.76
经营活动现金流出小计440,707,959.991,372,349,133.531,079,072,709.77702,971,135.62
经营活动产生的现金流量净额-24,869,922.89174,834,870.57139,496,057.94146,610,126.14
投资活动现金流入小计395,206,156.3842,125,374.19127,442,002.7140,823,879.27
投资活动现金流出小计46,905,875.39569,518,780.19232,744,777.1171,310,907.05
投资活动产生的现金流量净额348,300,280.99-527,393,406-105,302,774.39-130,487,027.78
筹资活动现金流入小计819,100,0002,774,199,4902,179,199,4901,581,599,490
筹资活动现金流出小计535,272,405.832,770,737,620.282,267,819,424.531,562,074,942.81
筹资活动产生的现金流量净额283,827,594.173,461,869.72-88,619,934.5319,524,547.19
汇率变动对现金及现金等价物的影响8,909,457.0635,694,131.3613,615,220.9910,444,385.43
现金及现金等价物净增加额616,167,409.33-313,402,534.35-40,811,429.9946,092,030.98
期末现金及现金等价物余额1,552,295,726.75936,128,317.421,208,719,421.781,295,622,882.75
TOP↑